Stage IIIA Bladder Cancer AJCC v8
Oncology
Prevalence
61.0 / 100K
Incidence
18.0 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Stage IIIA Bladder Cancer AJCC v8?
There are 1 clinical trial targeting Stage IIIA Bladder Cancer AJCC v8 tracked by BioSniper.
What is the prevalence of Stage IIIA Bladder Cancer AJCC v8?
The estimated prevalence of Stage IIIA Bladder Cancer AJCC v8 is approximately 61.0 per 100,000 population.
Deep-dive into Stage IIIA Bladder Cancer AJCC v8
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis